DM Research, Inc. v. College of American Pathologists

2 F. Supp. 2d 226, 1998 U.S. Dist. LEXIS 5700, 1998 WL 184898
CourtDistrict Court, D. Rhode Island
DecidedApril 14, 1998
DocketCivil Action 96-617
StatusPublished
Cited by9 cases

This text of 2 F. Supp. 2d 226 (DM Research, Inc. v. College of American Pathologists) is published on Counsel Stack Legal Research, covering District Court, D. Rhode Island primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
DM Research, Inc. v. College of American Pathologists, 2 F. Supp. 2d 226, 1998 U.S. Dist. LEXIS 5700, 1998 WL 184898 (D.R.I. 1998).

Opinion

MEMORANDUM AND ORDER

TORRES, District Judge.

The College of American Pathologists (CAP) and the National Committee for Clinical Laboratory Standards (NCCLS) have moved, pursuant to Fed.R.Civ.P. 12(b)(6) to dismiss the complaint filed by DM Research, Inc., (DM). The issue presented is whether the complaint states a claim for conspiracy to restrain trade in violation of § 1 of the Sherman Act. 15 U.S.C. § 1.

Because the facts alleged are insufficient to establish the existence of a conspiracy, the Sherman Act claim is dismissed, with prejudice, and the related state law claims are dismissed, without prejudice.

Background

The pertinent facts alleged in the complaint are as follows. DM produces Type I “Reagent Grade Water” that it bottles and sells to clinical laboratories for use in scientific testing. NCCLS is a non-profit corporation composed of hundreds of members throughout the United States. It develops and promotes standards for the clinical laboratory community which includes individual laboratories, laboratory professional associations, industries and governmental agencies. CAP is a non-profit corporation composed of hundreds of board-certified pathologists throughout the United States. It accredits medical laboratories and its purpose is to insure that the test results obtained from those laboratories are accurate.

In 1991, NCCLS published a guideline stating that Type I reagent water should be used immediately after being processed because it quickly degrades. Accordingly, the guideline encouraged the use of Type I water produced in-house on a daily basis instead of bottled water produced off site. The guideline also prescribes a limit for the concentration of ions in Type I water. Ion concentrations are determined by a resistivity test that measures the degree to which the water conducts electrical current.

CAP incorporated the NCCLS guideline into the checklist it utilizes in determining whether a hospital or laboratory should be or remain accredited. As a result, many laboratories purchased purification equipment and began producing their own Type I water. That, in turn, adversely affected DM’s sales.

DM’s four-count complaint asserts claims for: (1) conspiracy to restrain trade in violation of § 1 of the Sherman Act, 15 U.S.C. § 1; (2) conspiracy to restrain trade in violation of the Rhode Island Antitrust Act, R.I. Gen. Laws § 6-36-4; (3) tortious interference with existing and prospective business relationships and (4) defamation. The Sher *228 man Act claim is predicated on allegations that NCCLS and CAP “conspired to restrain trade” and that, in furtherance of the conspiracy, they adopted “faulty and arbitrary standards” and engage in unspecified “economic threats and intimidation of certain laboratories and referring pathologists to cease or refrain from doing business with DM Research and other bottled reagent water manufacturers.”

NCCLS and CAP make a number of different arguments in support of their motions to dismiss all of DM’s claims. However, there is no need to go beyond the argument that the complaint fails to state a claim for relief under the Sherman Act.

Standard of Review

A Rule 12(b)(6) motion to dismiss should be granted only if “it appears beyond doubt that the plaintiff can prove no set of facts in support of his claim which would entitle him to relief.” Conley v. Gibson, 355 U.S. 41, 45-46, 78 S.Ct. 99, 2 L.Ed.2d 80 (1957). In making that determination, the Court must “accept the well-pleaded factual averments of the ... complaint as true, and construe these facts in the light most flattering” to the plaintiff. Gooley v. Mobil Oil Corp., 851 F.2d 513, 514 (1st Cir.1988) (quoting Chongris v. Board of Appeals, 811 F.2d 36, 37 (1st Cir.1987)).

However, the complaint must allege facts that establish all of the elements of the claim asserted. Id. at 515; Car Carriers, Inc. v. Ford Motor Co., 745 F.2d 1101, 1106 (7th Cir.1984). Bald assertions, subjective characterizations and legal conclusions are insufficient. United States v. AVX Corp., 962 F.2d 108, 115 (1st Cir.1992); Dartmouth Review v. Dartmouth College, 889 F.2d 13, 16 (1st Cir.1989). Moreover, the factual allegations must be specific enough to justify “drag[ging] a defendant past the pleading threshold.” Gooley, 851 F.2d at 515.

These principles are especially applicable in antitrust cases where further litigation is likely to be protracted and expensive and, therefore, the impact of unfounded claims is severe. See Car Carriers, 745 F.2d at 1106-07; see also Faulkner Advertising Assocs. v. Nissan Motor Corp., 905 F.2d 769, 772 (4th Cir.1990) (antitrust complaint must “allege with reasonable definiteness facts from which the Court may infer conduct ... prohibited by the antitrust laws.”) (quoting Nelligan v. Ford Motor Co., 262 F.2d 556, 559 (4th Cir.1959)); Sut liff, Inc. v. Donovan Cos., 727 F.2d 648, 654 (7th Cir.1984) (bare legal conclusions do not prevent dismissal of antitrust claims); Bryan v. Stillwater Bd. of Realtors, 578 F.2d 1319, 1321 (10th Cir.1977) (conclusions or opinions are not sufficient to state an antitrust claim).

While antitrust complaints are not subjected to any heightened pleading requirements, courts must be vigilant to insure that the underlying facts in an antitrust complaint are pled with sufficient specificity to state a claim. Thus, an antitrust complaint “must contain either direct or inferential allegations respecting all the material elements necessary to sustain a recovery under some viable legal theory.” Car Carriers, 745 F.2d at 1106 (quoting In re Plywood Antitrust Litig., 655 F.2d 627, 641 (5th Cir.1981)) (emphasis in the original).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Ri Resource Rec. Corp. v. Brien
Superior Court of Rhode Island, 2011
Bay Area Mobile Medical v. Colagiovanni
Superior Court of Rhode Island, 2010
Gutierrez v. Molina
447 F. Supp. 2d 168 (D. Puerto Rico, 2006)
Gray v. Derderian
389 F. Supp. 2d 308 (D. Rhode Island, 2005)
Brunson Communications, Inc. v. Arbitron, Inc.
239 F. Supp. 2d 550 (E.D. Pennsylvania, 2002)

Cite This Page — Counsel Stack

Bluebook (online)
2 F. Supp. 2d 226, 1998 U.S. Dist. LEXIS 5700, 1998 WL 184898, Counsel Stack Legal Research, https://law.counselstack.com/opinion/dm-research-inc-v-college-of-american-pathologists-rid-1998.